Somatostatin agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546199, A61K 31445, C07D21114, C07D21140

Patent

active

06063796&

ABSTRACT:
This invention relates to somatostatin agonist compounds which are potent with high selectivity toward the receptor subtype 2. Compounds of the formula: ##STR1## including pharmaceutically acceptable salts and hydrates thereof are disclosed. These compounds are useful in the treatment of diabetes, cancer, acromegaly, restenosis, depression, irritable bowel syndrome, pain and diabetic retinopathy. Many of the compounds are also orally active.

REFERENCES:
patent: 4225472 (1980-09-01), Sarantakis
patent: 4242347 (1980-12-01), Huebner
patent: 4310518 (1982-01-01), Freidinger et al.
patent: 5360807 (1994-11-01), Janssens et al.
patent: 5767118 (1998-06-01), Nargund et al.
Spatola et al. "Amide bond surrogates: psudopeptides and macrocycles" Tetrhedron, v.44(3), p821-833, 1988.
Hansen et al. "Polypepties. VIII. synthesisof L-and D-2,6-diamino-4-hexynoic acid" CA 73::120889, 1970.
Hunter et al. "Identification and biosynthesis of N1, N9-bis(glutathionyl)aminopropylcadaverine in trypanosoma crizi" CA 121:296860, 1994.
Cavanak, T., et al., Chem. Abs., vol. 119, No. 23, Abs. No. 241372d, P. 69, 1993.
Maccoss, M., et al., Chem. Abs., vol. 128, No. 2, p. 386, Col. 1, Abs. No. 13436h, 1998.
Rudolf, K., et al., Chem. Abs., vol. 128, No. 19, p. 604, Abs. No. 230701v, 1998.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Somatostatin agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Somatostatin agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Somatostatin agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-259206

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.